Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis – Authors' reply

Emma Guttman-Yassky; Eric L. Simpson; Kristian Reich; Kenji Kabashima; Ken Igawa; Tetsuya Suzuki; Hirotaka Mano; Takeshi Matsui; Ehsanollah Esfandiari; Masutaka Furue

doi:10.1016/S0140-6736(23)01618-5

Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis – Authors' reply

Emma Guttman-Yassky, Eric L. Simpson, Kristian Reich, Kenji Kabashima, Ken Igawa, Tetsuya Suzuki, Hirotaka Mano, Takeshi Matsui, Ehsanollah Esfandiari, Masutaka Furue

Dermatology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1834
Number of pages	1
Journal	The Lancet
Volume	402
Issue number	10415
DOIs	https://doi.org/10.1016/S0140-6736(23)01618-5
State	Published - Nov 18 2023

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(23)01618-5

Cite this

@article{c8b30b26ab444aac8251fd4b5455a180,

title = "Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis – Authors' reply",

author = "Emma Guttman-Yassky and Simpson, {Eric L.} and Kristian Reich and Kenji Kabashima and Ken Igawa and Tetsuya Suzuki and Hirotaka Mano and Takeshi Matsui and Ehsanollah Esfandiari and Masutaka Furue",

year = "2023",

month = nov,

day = "18",

doi = "10.1016/S0140-6736(23)01618-5",

language = "English (US)",

volume = "402",

pages = "1834",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10415",

}

TY - JOUR

T1 - Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis – Authors' reply

AU - Guttman-Yassky, Emma

AU - Simpson, Eric L.

AU - Reich, Kristian

AU - Kabashima, Kenji

AU - Igawa, Ken

AU - Suzuki, Tetsuya

AU - Mano, Hirotaka

AU - Matsui, Takeshi

AU - Esfandiari, Ehsanollah

AU - Furue, Masutaka

PY - 2023/11/18

Y1 - 2023/11/18

UR - http://www.scopus.com/inward/record.url?scp=85176798645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85176798645&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(23)01618-5

DO - 10.1016/S0140-6736(23)01618-5

M3 - Letter

C2 - 37980090

AN - SCOPUS:85176798645

SN - 0140-6736

VL - 402

SP - 1834

JO - The Lancet

JF - The Lancet

IS - 10415

ER -

Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis – Authors' reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this